SCHEMBL18895982

SCHEMBL18895982

CC/C=C1\C2=CC=NC2Oc2ccc(C(C)(C)O)cc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18895983 0.81 CCR1 (0.32) —
SCHEMBL12121700 0.70 CYP19A1 (0.31) —
SCHEMBL933157 0.51 CYP3A4 (0.50) —
SCHEMBL30033480 0.50 ESR1 (0.39) —
SCHEMBL29014630 0.50 ESR1 (0.39) —
SCHEMBL196799 0.50 MEN1 (0.48) —
SCHEMBL547724 0.50 PTPN1 (0.40) —
SCHEMBL6931883 0.49 MEN1 (0.34) —
SCHEMBL12463520 0.49 CYP19A1 (0.39) —
SCHEMBL6931875 0.49 ABL1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663537-B2 Chemokine receptor antagonists and methods of use MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-05-30 — — US disclosed
Send feedback